IL6 and neoplasm: Tumor-associated M2 macrophages and their YY1 are highly expressed, and LLPS of the YY1 complex upregulates interleukin (IL)-6 levels in the tumor microenvironment by promoting IL-6 enhancer-promoter interactions, leading to PCa progression (136).